Breaking News
5 minutes ago
Simantini Singh Deo
Biogen secures EU approval for a high-dose SPINRAZA regimen, offering a more rapid loading phase for patients with SMA.
Simantini Singh Deo
Biocartis teams up with Mayo Clinic to advance an investigational rapid breast cancer test aimed at reducing diagnostic delays.
Simantini Singh Deo
Achieve Life Sciences confirms Mark Rubinstein, MD, as Chief Medical Officer, strengthening leadership as cytisinicline nears FDA review.
Simantini Singh Deo
Royalty Pharma backs Teva with up to $500M to accelerate clinical development of the anti-IL-15 antibody TEV-408.
Simantini Singh Deo